Three-dimensional reconstruction/personalized three-dimensional printed model for thoracoscopic anatomical partial-lobectomy in stage I lung cancer: a retrospective study.
Bin Qiu, Ying Ji, Huayu He...
https://pubmed.ncbi.nlm.nih.gov/32953501/Actively Recruiting
Led by Qilu Hospital of Shandong University · Updated on 2026-10-01
274
Participants Needed
4
Research Sites
N/A
Total Duration
Researchers are evaluating a new method called intraoperative longitude-latitude-depth LLD localization for identifying small peripheral pulmonary nodules in adults undergoing video-assisted thoracoscopic surgery VATS. This study compares the LLD technique to the standard preoperative CT-guided percutaneous lung puncture localization to see if LLD is not worse in accuracy and if it improves safety and perioperative outcomes. The trial focuses on nodules between 0.8 and 2 cm and aims to provide strong evidence about these two localization methods in surgical treatment. Participants will be randomly assigned to one of two groups. One group receives the LLD localization during surgery using anatomical reference lines and preoperative CT measurements without any puncture, followed by VATS-assisted sublobar resection. The other group undergoes the standard CT-guided lung puncture localization before surgery, followed by the same surgical resection. Both methods guide surgeons to accurately locate and remove the pulmonary nodules. During the study, participants will be monitored for localization accuracy immediately during surgery and for safety and recovery outcomes including complications, localization time, chest drainage removal, oxygen levels, hospital stay length, pain scores, and quality of life up to six months after surgery. Follow-up assessments occur at 1, 3, and 6 months post-surgery to evaluate long-term recovery and well-being.
CONDITIONS
Intraoperative Longitude-Latitude-Depth Localization Versus Preoperative CT-Guided Percutaneous Lung Puncture Localization for 0.8-2 cm Peripheral Pulmonary Nodules
Z
Zhenguo Sun, Doctor of Medicine (MD)
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Qilu Hospital of Shandong University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day 0 (same day)
Participants undergo pulmonary nodule localization using either the LLD method during surgery or CT-guided percutaneous puncture before surgery, followed by video-assisted thoracoscopic surgery (VATS)-assisted sublobar resection.
1 surgical visit
Duration - 6 months
Participants are monitored for recovery, including complications, pain, oxygen levels, chest drainage removal, hospital stay, and quality of life through assessments at 1, 3, and 6 months after surgery.
Follow-up visits at 1, 3, and 6 months post-surgery
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Bin Qiu, Ying Ji, Huayu He...
https://pubmed.ncbi.nlm.nih.gov/32953501/Daniel E Jonas, Daniel S Reuland, Shivani M Reddy...
https://pubmed.ncbi.nlm.nih.gov/33687468/K Suzuki, K Nagai, J Yoshida...
https://pubmed.ncbi.nlm.nih.gov/10027460/Chao Zhou, Xinming Li, Wentao Li...
https://pubmed.ncbi.nlm.nih.gov/33717587/Chul Hwan Park, Kyunghwa Han, Jin Hur...
https://pubmed.ncbi.nlm.nih.gov/27717643/Binjie Zhang, Yongkui Zhang, Hanbo Le...
https://pubmed.ncbi.nlm.nih.gov/35116651/Yue Zhao, Jianhao Qiu, Anna Bright...
https://pubmed.ncbi.nlm.nih.gov/39958213/Qilu Hospital of Shandong University
Lead Sponsor